As far as revenue raise goes, in the 10Q mgmt states they anticipate having enough cash for the next 12 months. However in the conf call during question answer time they alluded to having additional logistics locations in planning, which may affect gross margin numbers. If they build out I can see a need to raise capital, either equity or debt.
For one time expenses would debt be a more favorable avenue?
Im in the 'hope for a buyout' heard, as listening to call felt like any revenue ramp is still a long ways off...think years. The two fda approvals are only expected to be be fully ramped in 3 years.
Im now thinking about selling common and buying tradable warrants...just not sure where the bottom is right now...
News 
Market Data 
Discover 
